tetraethylammonium has been researched along with Acute Disease in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We tested the effects of inhibitors of calcium-dependent K(+) channels [iberiotoxin (50 nM) and tetraethylammonium (TEA, 1 mM)] on changes in arteriolar diameter during acute hypertension." | 3.70 | Potassium channels modulate cerebral autoregulation during acute hypertension. ( Faraci, FM; Heistad, DD; Paternò, R, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paternò, R | 1 |
| Heistad, DD | 1 |
| Faraci, FM | 1 |
1 other study available for tetraethylammonium and Acute Disease
| Article | Year |
|---|---|
Potassium channels modulate cerebral autoregulation during acute hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4-Aminopyridine; Acute Disease; | 2000 |